Overview

• US healthcare cost management firm's fiscal Q4 revenue grew 7% yr/yr, EPS up 20%

• Company repurchased $20.1 mln of common stock during the quarter

• CERIS division benefited from industry shift to proactive payment accuracy and cost management

Outlook

• Company highlights strong demand for CERIS platform and increased revenue visibility from new contracts

• CorVel says ongoing investment in AI and automation expected to support margins and scalability

• Company expects technology and automation to improve operational efficiency and claim outcomes

Result Drivers

• CERIS DEMAND - Co said CERIS division saw strong demand due to healthcare industry's shift toward proactive payment accuracy and cost management

• LARGE PAYER SALES - Co said multiple large payer sales with enterprise-scale implementations increased revenue visibility as they are deployed and scaled

• TECHNOLOGY INVESTMENT - Co said ongoing investments in AI, automation, and technology-enabled models improved operational efficiency and claim outcomes

Company press release: ID:nGNX5VLWtZ

Key Details

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.